183 related articles for article (PubMed ID: 19587741)
1. Human genetics: One gene, twenty years.
Pearson H
Nature; 2009 Jul; 460(7252):164-9. PubMed ID: 19587741
[No Abstract] [Full Text] [Related]
2. Genetics. The promise of a cure: 20 years and counting.
Couzin-Frankel J
Science; 2009 Jun; 324(5934):1504-7. PubMed ID: 19541969
[No Abstract] [Full Text] [Related]
3. Genetic heterogeneity and cystic fibrosis.
Cutting GR
Hum Mutat; 2009 Jul; 30(7):v. PubMed ID: 19551760
[No Abstract] [Full Text] [Related]
4. A combination therapy for cystic fibrosis.
Brodsky JL; Frizzell RA
Cell; 2015 Sep; 163(1):17. PubMed ID: 26406363
[TBL] [Abstract][Full Text] [Related]
5. 50 years ago in the Journal of Pediatrics: A note on studies of salt excretion in sweat: relationships between rate, conductivity, and electrolyte composition of sweat from patients with cystic fibrosis and from control subjects. Gibson, LE, di Sant’Agnese, PA. J Pediatr 1963;62:855-67.
Gonska T
J Pediatr; 2013 Jun; 162(6):1187. PubMed ID: 23708418
[No Abstract] [Full Text] [Related]
6. Terminal glycosylation and disease: influence on cancer and cystic fibrosis.
Scanlin TF; Glick MC
Glycoconj J; 2000; 17(7-9):617-26. PubMed ID: 11421353
[TBL] [Abstract][Full Text] [Related]
7. Drug bests cystic-fibrosis mutation.
Ledford H
Nature; 2012 Feb; 482(7384):145. PubMed ID: 22318583
[No Abstract] [Full Text] [Related]
8. [Historical compilation of cystic fibrosis].
Navarro S
Gastroenterol Hepatol; 2016 Jan; 39(1):36-42. PubMed ID: 26070393
[TBL] [Abstract][Full Text] [Related]
9. Current status of CF gene therapy.
Boucher RC
Trends Genet; 1996 Mar; 12(3):81-4. PubMed ID: 8868343
[No Abstract] [Full Text] [Related]
10. Evaluation of repeat administration of a replication deficient, recombinant adenovirus containing the normal cystic fibrosis transmembrane conductance regulator cDNA to the airways of individuals with cystic fibrosis.
Crystal RG; Mastrangeli A; Sanders A; Cooke J; King T; Gilbert F; Henschke C; Pascal W; Herena J; Harvey BG
Hum Gene Ther; 1995 May; 6(5):667-703. PubMed ID: 7578402
[No Abstract] [Full Text] [Related]
11. Open channels: Do new cystic-fibrosis therapies hold the key to treating other genetic disorders?
Groopman J
New Yorker; 2009 May; ():30-4. PubMed ID: 19408414
[No Abstract] [Full Text] [Related]
12. A Personal Reflection from London.
Thrasher AJ
Hum Gene Ther; 2017 Nov; 28(11):959. PubMed ID: 29035116
[No Abstract] [Full Text] [Related]
13. Gene therapy for cystic fibrosis: perspectives for the otolaryngologist.
Graham SM
Clin Otolaryngol Allied Sci; 1998 Dec; 23(6):481-3. PubMed ID: 9884799
[No Abstract] [Full Text] [Related]
14. Personalized medicine in CF: from modulator development to therapy for cystic fibrosis patients with rare CFTR mutations.
Harutyunyan M; Huang Y; Mun KS; Yang F; Arora K; Naren AP
Am J Physiol Lung Cell Mol Physiol; 2018 Apr; 314(4):L529-L543. PubMed ID: 29351449
[TBL] [Abstract][Full Text] [Related]
15. 50 Years ago in The Journal of Pediatrics: hypoproteinemia and edema in infants with cystic fibrosis of the pancreas.
Palermo J; Szabo F
J Pediatr; 2014 Mar; 164(3):638. PubMed ID: 24560318
[No Abstract] [Full Text] [Related]
16. Intestinal organoids to model cystic fibrosis.
van Mourik P; Beekman JM; van der Ent CK
Eur Respir J; 2019 Jul; 54(1):. PubMed ID: 31023844
[No Abstract] [Full Text] [Related]
17. The pathogenesis of cystic fibrosis and progress towards gene therapy.
Stern M; Alton E
J R Coll Physicians Lond; 1999; 33(5):434-9. PubMed ID: 10624657
[No Abstract] [Full Text] [Related]
18. Cystic fibrosis transmembrane regulator protein mutations: 'class' opportunity for novel drug innovation.
MacDonald KD; McKenzie KR; Zeitlin PL
Paediatr Drugs; 2007; 9(1):1-10. PubMed ID: 17291132
[TBL] [Abstract][Full Text] [Related]
19. Topical cystic fibrosis transmembrane conductance regulator gene replacement for cystic fibrosis-related lung disease.
Perry LA; Penny-Dimri JC; Aslam AA; Lee TW; Southern KW
Paediatr Respir Rev; 2017 Mar; 22():47-49. PubMed ID: 27964951
[No Abstract] [Full Text] [Related]
20. Clinical trial research in focus: ensuring new cystic fibrosis drugs fulfil their potential.
Elborn JS; Davies J
Lancet Respir Med; 2017 Sep; 5(9):681-683. PubMed ID: 28853396
[No Abstract] [Full Text] [Related]
[Next] [New Search]
